GO:0007218 neuropeptide signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007218 (neuropeptide signaling pathway) is a biological process defined as a G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, ending with regulation of a downstream cellular process.
• Neuropeptides are short signaling peptides released from neurons that act on GPCRs to modulate neuronal excitability, synaptic plasticity, pain, feeding, reproduction, and behavior.
• The pathway is conserved across invertebrates and vertebrates, with well-characterized examples including oxytocin/vasopressin-like peptides in insects and FLP-14/FRPR-19 in C. elegans.
• Neuropeptide signaling regulates synaptic growth and nociceptive sensitization, linking neuronal activity to structural and behavioral plasticity.
• Dysregulated neuropeptide signaling is implicated in pain, cancer progression, osteoarthritis, and neurological disorders.
• CRISPR knockout, knock-in, point mutation, and overexpression models enable causal dissection of neuropeptide-receptor pathways in vitro and in vivo.
Description
The neuropeptide signaling pathway (GO:0007218) is a biological process in which a neuropeptide binds to a G protein-coupled receptor (GPCR) on the surface of a target cell, initiating a signaling cascade that culminates in regulation of a downstream cellular process. Neuropeptides are short, neuron-derived peptides that act as neuromodulators or neurotransmitters, and their receptors are among the largest families of GPCRs in metazoan genomes. Because this pathway converts neuronal activity into changes in excitability, gene expression, and behavior, it is central to understanding how nervous systems integrate internal states with external stimuli. Research across model organisms has revealed that neuropeptide signaling is both structurally complex and functionally pleiotropic. In Caenorhabditis elegans, a large network of neuropeptide genes and GPCRs controls locomotion, nociception, and foraging behavior. In Drosophila, neuropeptide signaling regulates synaptic growth and circadian output. In insects, oxytocin/vasopressin-like peptides control water balance, reproduction, and social behavior. These findings establish GO:0007218 as a conserved and experimentally tractable process for dissecting neuronal communication. For biomedical researchers, the pathway is directly relevant to human disease. Neuropeptide signaling modulates pain processing in osteoarthritis and cancer, where sensory neuron-derived neuropeptides can promote tumor progression. Consequently, genes encoding neuropeptides and their GPCRs are candidate therapeutic targets and are increasingly studied using CRISPR-based functional genomics.
neuropeptide signaling pathway At A Glance
| GO ID | GO:0007218 |
|---|---|
| GO term | neuropeptide signaling pathway |
| Ontology | biological_process |
| Synonym | neuropeptide signalling pathway |
| Definition | A G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. |
| Major function | Transduces neuropeptide signals via GPCRs to modulate neuronal excitability, synaptic plasticity, and behavior. |
| Conservation | Present in invertebrates and vertebrates, including insects, C. elegans, Drosophila, and mammals. |
| Key receptor class | G protein-coupled receptors (GPCRs). |
| Representative ligands | Oxytocin/vasopressin-like peptides, FLP-14, and other neuropeptides. |
What Is GO:0007218?
According to the Gene Ontology, GO:0007218 (neuropeptide signaling pathway) is defined as a G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. In simpler terms, it is the entire sequence of events from a neuropeptide docking onto its GPCR to the resulting change in cell behavior, such as altered excitability, enzyme activity, or gene transcription.
Why Is neuropeptide signaling pathway Important in Cell Biology?
GO:0007218 is important because it provides a mechanistic framework for understanding how neurons communicate via secreted peptides to control physiology and behavior. Unlike fast synaptic transmission, neuropeptide signaling often acts over longer timescales and can diffuse to modulate entire circuits, making it a key regulator of pain, stress responses, feeding, reproduction, and social behavior. Its dysfunction is linked to human pathologies including chronic pain, osteoarthritis, and cancer progression, where sensory neuron-derived neuropeptides promote tumor growth. Because the pathway is genetically tractable in model organisms and druggable at the GPCR level, it is a high-value target for both basic neuroscience and translational research.
• Controls neuronal excitability and synaptic plasticity through GPCR-mediated signaling.
• Regulates nociception and pain sensitization, as shown for the FLP-14/FRPR-19 pathway in C. elegans.
• Modulates pain in osteoarthritis via calcitonin-related mechanisms.
• Promotes breast cancer progression through sensory neuron-derived neuropeptides and κ-opioid counter-regulation.
• Regulates synaptic growth in Drosophila, linking neuropeptide signaling to structural plasticity.
• Controls water balance, reproduction, and social behavior in insects via oxytocin/vasopressin-like peptides.
• Provides a conserved model for dissecting GPCR signaling networks in C. elegans.
• Offers druggable GPCR targets for neurological and oncological indications.
• Enables CRISPR-based functional genomics of neuropeptide-receptor pairs.
• Serves as a paradigm for understanding how neuromodulators shape behavior.
What Happens During neuropeptide signaling pathway?
Neuropeptide synthesis, packaging, and release
In simple terms: Neurons make small peptide signals, store them in vesicles, and release them when the neuron is active.
Neuropeptides are synthesized as larger precursor proteins that are cleaved and post-translationally modified before being packaged into dense-core vesicles. In insects, oxytocin/vasopressin-like neuropeptides are processed from precursors and released to act on peripheral and central targets. In C. elegans, neuropeptide genes such as flp-14 encode precursors that give rise to mature peptides acting on FRPR-19. Release occurs in response to neuronal activity, allowing neuropeptides to act as neuromodulators.
Receptor binding and GPCR activation
In simple terms: The released peptide docks onto a receptor on the target cell, switching the receptor on.
The defining step of GO:0007218 is the binding of a neuropeptide to a G protein-coupled receptor on the surface of a target cell. This interaction stabilizes an active receptor conformation that catalyzes guanine nucleotide exchange on heterotrimeric G proteins. In Drosophila, neuropeptide GPCRs mediate diverse outputs including synaptic growth regulation. In C. elegans, the FRPR-19 GPCR is activated by FLP-14 to sustain nociceptive responses.
Intracellular signal transduction
In simple terms: Activated receptors trigger second messengers inside the cell that amplify and spread the signal.
Activated GPCRs stimulate downstream effectors such as adenylyl cyclase, phospholipase C, and ion channels, generating second messengers including cAMP, IP3, and calcium. These signals propagate to kinases and other regulatory proteins that modify neuronal excitability and gene expression. In C. elegans, FLP-14/FRPR-19 signaling sustains nociceptive sensitization through such intracellular cascades. In insects, oxytocin/vasopressin-like peptide signaling engages conserved G protein pathways.
Regulation of downstream cellular processes
In simple terms: The signal ultimately changes how the cell behaves, such as firing more easily or growing new synapses.
The pathway ends with regulation of a downstream cellular process, which may include changes in ion channel activity, synaptic growth, or transcriptional programs. In Drosophila, a neuropeptide signaling pathway regulates synaptic growth at the neuromuscular junction. In C. elegans, neuropeptide signaling shapes locomotion and foraging behavior. In mammals, neuropeptide signaling modulates pain and cancer progression.
Termination and desensitization
In simple terms: The cell shuts the signal off to avoid overstimulation.
Following activation, GPCRs are desensitized by phosphorylation and arrestin recruitment, and neuropeptides are degraded by extracellular peptidases. This termination step is essential for restoring baseline excitability and preventing pathological overactivation. In C. elegans, sustained nociceptive responses require continued FLP-14/FRPR-19 signaling, indicating that termination is tightly regulated. In insects, peptide degradation and receptor internalization contribute to signal termination.
Key Genes Involved in GO:0007218 neuropeptide signaling pathway
The following genes and proteins are representative components of the neuropeptide signaling pathway (GO:0007218) across model organisms and human biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FLP-14 | Neuropeptide ligand in C. elegans | Sustains nociceptive response to repeated noxious stimuli |
| FRPR-19 | GPCR receptor for FLP-14 in C. elegans | Mediates nociceptive sensitization |
| Oxytocin/vasopressin-like peptides | Insect neuropeptides controlling water balance and behavior | Model for conserved neuropeptide signaling |
| Drosophila neuropeptide GPCRs | Receptors regulating synaptic growth and behavior | Genetic dissection of neuropeptide pathways |
| Calcitonin | Neuropeptide modulating pain in osteoarthritis | Pain-related neuromodulation |
| κ-opioid receptor | Counter-regulates neuropeptide-driven cancer progression | Breast cancer neuropeptide signaling |
| C. elegans neuropeptide network | Large set of neuropeptide genes and GPCRs | Systems-level analysis of neuropeptide signaling |
| Insect neuropeptide precursors | Produce mature neuropeptides | Comparative neuropeptide biology |
| Drosophila synaptic growth regulators | Neuropeptide pathway components | Synaptic plasticity studies |
| Sensory neuron neuropeptides | Released in tumor microenvironment | Cancer progression mechanisms |
| Calcitonin-related peptides | Modulate joint pain | Osteoarthritis models |
| C. elegans FRPR family GPCRs | Neuropeptide receptors | Behavioral genetics |
| Insect oxytocin/vasopressin receptors | Mediate peptide signaling | Insect physiology |
| Drosophila neuropeptide genes | Encode peptide ligands | Circadian and behavioral studies |
| Mammalian neuropeptide GPCRs | Broad neuromodulation | Drug target discovery |
| FLP neuropeptide family | C. elegans ligands | Nociception and behavior |
| Neuropeptide processing enzymes | Cleave precursors | Biochemistry of peptide maturation |
| GPCR kinases and arrestins | Desensitize receptors | Signal termination studies |
How Is neuropeptide signaling pathway Regulated?
Neuropeptide signaling is regulated at multiple levels, including peptide synthesis, vesicular release, receptor availability, and desensitization. In C. elegans, sustained nociceptive responses depend on continued FLP-14/FRPR-19 signaling, indicating activity-dependent regulation of the pathway. In Drosophila, neuropeptide signaling is integrated with synaptic growth programs, suggesting developmental and activity-dependent control. In insects, oxytocin/vasopressin-like peptide signaling is modulated by physiological state such as hydration and reproductive status. GPCR desensitization by kinases and arrestins provides a conserved negative feedback mechanism.
neuropeptide signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Calcitonin | Knee osteoarthritis pain | Knockout or overexpression in chondrocyte/neuron co-culture |
| Sensory neuron neuropeptides | Breast cancer progression | Conditional knockout in sensory neurons in mouse tumor models |
| FLP-14/FRPR-19 | Nociceptive sensitization | C. elegans knockout and rescue |
| Drosophila neuropeptide pathway | Synaptic growth disorders | Drosophila knockout and overexpression |
| Oxytocin/vasopressin-like peptides | Insect physiology and behavior | Insect knockout and knock-in |
Neuropeptide signaling in pain and osteoarthritis
Neuropeptides modulate nociceptive processing, and dysregulation can contribute to chronic pain. Calcitonin has been shown to modulate pain-related neuromodulation mechanisms in knee osteoarthritis, highlighting the clinical relevance of neuropeptide signaling in joint disease. In C. elegans, the FLP-14/FRPR-19 pathway sustains nociceptive responses to repeated noxious stimuli, providing a genetic model for sensitization.
Neuropeptide signaling in cancer progression
Sensory neurons can release neuropeptides into the tumor microenvironment, promoting cancer progression. Pain signaling via sensory neurons drives breast cancer progression through neuropeptide release, with κ-opioid counter-regulation modulating this effect. This establishes neuropeptide signaling as a mechanistic link between the nervous system and tumor biology.
Neuropeptide signaling in neurological and behavioral disorders
Because neuropeptides regulate synaptic plasticity and behavior, their dysfunction is implicated in neurological and psychiatric conditions. In Drosophila, neuropeptide signaling regulates synaptic growth, providing a model for structural plasticity. In C. elegans, the neuropeptide signaling network controls behavior, offering a platform for dissecting conserved mechanisms. Insect oxytocin/vasopressin-like signaling serves as a comparative model for social and reproductive behaviors.
From neuropeptide signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a neuropeptide receptor required for nociception? | CRISPR knockout of FRPR-19 in C. elegans |
| Does a point mutation in a GPCR alter ligand binding? | CRISPR point mutation knock-in in Drosophila or mammalian cells |
| Can a tagged neuropeptide be tracked in vivo? | Knock-in of fluorescent tag at the neuropeptide locus |
| Does overexpression of a neuropeptide drive cancer progression? | Overexpression in sensory neurons or tumor models |
| Which neuropeptide genes regulate synaptic growth? | CRISPR library screening in Drosophila neurons |
| Does calcitonin signaling modulate osteoarthritis pain? | Knockout and overexpression in joint tissue models |
How to Study the neuropeptide signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Testing requirement of neuropeptide/receptor |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking neuropeptide localization |
| RNA-seq | Transcript levels | Mapping neuropeptide gene expression |
| Neuropeptidomics | Mature peptide profiles | Identifying processed neuropeptides |
| Calcium imaging | Neuronal activity | Measuring GPCR activation |
| Behavioral assays | Nociception, locomotion | Linking pathway to behavior |
| Electrophysiology | Excitability changes | Assessing neuromodulation |
| GPCR biosensors | Real-time receptor activation | Visualizing neuropeptide signaling |
Genetic knockout and rescue
CRISPR knockout of neuropeptide or receptor genes followed by rescue experiments can establish causality. In C. elegans, knockout of flp-14 or frpr-19 abolishes sustained nociceptive responses, and rescue restores them. Similar approaches in Drosophila have identified neuropeptide pathway components regulating synaptic growth.
Transcriptomics and neuropeptidomics
RNA sequencing and mass spectrometry-based neuropeptidomics can map expression of neuropeptide precursors and receptors. The C. elegans neuropeptide signaling network has been characterized using such approaches, revealing dozens of ligands and GPCRs. Insect neuropeptide signaling has similarly been dissected using peptidomics.
Behavioral and electrophysiological assays
Behavioral assays in C. elegans and Drosophila link neuropeptide signaling to nociception, locomotion, and synaptic growth. Electrophysiology can measure changes in neuronal excitability downstream of GPCR activation.
Imaging and GPCR biosensors
Genetically encoded GPCR biosensors and calcium imaging can visualize neuropeptide release and receptor activation in vivo. These tools have been applied to insect oxytocin/vasopressin-like signaling and Drosophila neuropeptide circuits.
How CRISPR Can Be Used to Study GO:0007218 neuropeptide signaling pathway
Knockout
CRISPR knockout of neuropeptide ligands or their GPCRs is used to test necessity. For example, knockout of flp-14 or frpr-19 in C. elegans abolishes sustained nociceptive responses, demonstrating the pathway's role in sensitization. Knockout of neuropeptide pathway genes in Drosophila reveals roles in synaptic growth.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid changes in GPCRs or neuropeptides to dissect binding determinants and signaling bias. Such approaches are valuable for studying receptor-ligand interfaces in neuropeptide signaling.
Knock-in
Knock-in of fluorescent or epitope tags at endogenous neuropeptide loci enables real-time tracking of peptide expression and release. This has been applied to neuropeptide systems in C. elegans and Drosophila.
Overexpression
Overexpression of neuropeptides or receptors can test sufficiency and model pathological states. Overexpression of sensory neuron-derived neuropeptides promotes breast cancer progression in mouse models. Overexpression in Drosophila can drive synaptic overgrowth.
How EDITGENE Supports neuropeptide signaling pathway Research
Researchers studying neuropeptide signaling pathway-related genes often need to determine whether a candidate gene is causally involved in a specific neuronal or disease phenotype. This requires precise genetic models that can knock out, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for neuropeptide signaling pathway research.
Frequently Asked Questions About neuropeptide signaling pathway
What is the neuropeptide signaling pathway GO:0007218?
It is a biological process defined as a G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, ending with regulation of a downstream cellular process.
What genes are involved in neuropeptide signaling pathway?
Genes include neuropeptide ligands such as FLP-14 and oxytocin/vasopressin-like peptides, and their GPCRs such as FRPR-19, as well as downstream signaling components.
How does neuropeptide signaling work?
Neuropeptides are released from neurons, bind to GPCRs on target cells, activate G proteins and second messengers, and ultimately change neuronal excitability or gene expression.
What is the role of neuropeptide signaling in pain?
Neuropeptide signaling modulates nociception; calcitonin signaling is involved in osteoarthritis pain, and the FLP-14/FRPR-19 pathway sustains nociceptive sensitization.
Is neuropeptide signaling involved in cancer?
Yes, sensory neuron-derived neuropeptides can promote breast cancer progression, with κ-opioid counter-regulation modulating this effect.
Which model organisms are used to study neuropeptide signaling?
C. elegans, Drosophila, and insects are widely used because of their tractable genetics and conserved neuropeptide systems.
What are the main receptors in neuropeptide signaling?
The main receptors are G protein-coupled receptors (GPCRs) that bind neuropeptides on the cell surface.
How can CRISPR be used to study neuropeptide signaling?
CRISPR knockout, knock-in, point mutation, and overexpression can test the necessity and sufficiency of neuropeptide pathway genes in vivo and in vitro.
What diseases are linked to neuropeptide signaling dysfunction?
Diseases include chronic pain, osteoarthritis, and cancer progression, as well as neurological and behavioral disorders.
What methods are used to study neuropeptide signaling pathway?
Methods include CRISPR screens, RNA-seq, neuropeptidomics, calcium imaging, electrophysiology, and behavioral assays.
Conclusion
GO:0007218 (neuropeptide signaling pathway) is a conserved biological process that converts neuropeptide binding at GPCRs into changes in neuronal function and behavior. Its roles in nociception, synaptic growth, and cancer progression make it a high-priority area for both basic and translational research. CRISPR-based models, combined with transcriptomics, neuropeptidomics, and imaging, provide powerful tools to dissect this pathway. EDITGENE supports researchers with customized knockout, knock-in, point mutation, overexpression, and library screening services to accelerate discovery in neuropeptide signaling.
References
- 1. Muratspahić E et al.. 2020. Oxytocin/vasopressin-like neuropeptide signaling in insects.. Vitam Horm 113:29-53 PMID: 32138952
- 2. Lin Q et al.. 2025. Verification of Pain-Related Neuromodulation Mechanisms of Calcitonin in Knee Osteoarthritis.. Mol Neurobiol 62(7):8341-8358 PMID: 39994161
- 3. Makabe H et al.. 2026. Pain signaling via sensory neurons drives breast cancer progression through neuropeptide release and κ-opioid counter-regulation.. Pharmacol Res 225:108113 PMID: 41616927
- 4. Watteyne J et al.. 2024. Neuropeptide signaling network of Caenorhabditis elegans: from structure to behavior.. Genetics 228(3) PMID: 39344922
- 5. Altstein M et al.. 2010. Neuropeptide signaling in insects.. Adv Exp Med Biol 692:155-65 PMID: 21189678
- 6. Marques F et al.. 2021. Signaling via the FLP-14/FRPR-19 neuropeptide pathway sustains nociceptive response to repeated noxious stimuli in C. elegans.. PLoS Genet 17(11):e1009880 PMID: 34748554
- 7. Taghert PH et al.. 2003. Drosophila neuropeptide signaling.. Adv Genet 49:1-65 PMID: 12779250
- 8. Chen X et al.. 2012. A neuropeptide signaling pathway regulates synaptic growth in Drosophila.. J Cell Biol 196(4):529-43 PMID: 22331845
